Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
1,274 total articles
Scorpio Tankers Inc., a marine transportation company specializing in petroleum products, has entered into agreements to sell two 2015-built scrubber-fitted MR product tankers, STI Brooklyn and STI Black Hawk, for $35 million each. The sales are expected to close in the second quarter of 2026. The company also disclosed agreements to sell additiona…
Rezolve Ai, a leader in AI-powered retail infrastructure, delivered $46.8M revenue for 2025, significantly exceeding market expectations with an explosive second half growth of 543%. The company ended 2025 at a $232M Annual Recurring Revenue (ARR) run rate and raised its 2026 revenue guidance to $360M with an anticipated ARR exit of $500M. Strong f…
Sagtec Global Limited (NASDAQ: SAGT) is launching its proprietary Sovereign AI Data Center through its subsidiary CL Technologies (International) Sdn Bhd. This facility, powered by NVIDIA GPU architecture, is designed to support millions of daily transactions in food & beverage (F&B) retail ordering, retail operations, and fintech, marking a strate…
SiriusPoint Ltd., a specialty underwriter listed on the NYSE, has appointed Sabra Purtill to its Board of Directors while Franklin Montross IV and Peter Tan will step down in May 2026. The company highlights its focus on discipline, resilience, and long-term value as it evolves its governance and strategic direction.
Ruanyun Edai Technology Inc., an AI-driven education technology company listed on NASDAQ under the ticker RYET, announced unaudited interim financial results for the six months ending September 30, 2025. The company experienced a sharp 91.1% decline in revenue compared to the previous year, coupled with a substantial increase in net loss to over $4…
Aprea Therapeutics announced a confirmed partial response in their ongoing Phase 1 ACESOT-1051 trial for APR-1051, a selective WEE1 kinase inhibitor targeting biomarker-defined cancers. The response was observed at the 220 mg dose in a patient with PPP2R1A-mutated endometrial cancer, with sustained tumor reduction and decreasing CA-125 levels. The …
Regency Centers Corporation, a leading REIT and S&P 500 member specializing in suburban retail shopping centers, is set to release its first quarter 2026 earnings after market close on April 29, 2026, with a conference call scheduled the following day. Investors can access the earnings report and webcast via the company's Investor Relations website…
Plains All American Pipeline, L.P. and Plains GP Holdings announced an updated expected closing date for the sale of their Canadian natural gas liquids (NGL) business to Keyera Corp, now anticipated in May 2026 following ongoing regulatory review. The transaction aims to reposition Plains as a pure play crude oil midstream company with integrated N…
Nasdaq has completed its public consultation regarding proposed enhancements to the Nasdaq-100 Index methodology. After reviewing stakeholder feedback, Nasdaq Global Indexes approved updates that will be implemented starting May 1, 2026. These changes aim to improve the index's rules and reflect ongoing governance and market transparency efforts.
Standard Lithium Ltd. announced strong fourth quarter and full year 2025 results highlighted by signing its first binding offtake agreement to supply 8,000 tonnes per year of battery-grade lithium carbonate to Trafigura over 10 years. The company received over $1 billion in project finance indications and progressed towards a final investment decis…
Beta Bionics, a Nasdaq-listed company specializing in advanced diabetes management devices, announced it will report its first quarter 2026 financial results on April 21, 2026. The company will host a conference call and webcast to discuss the performance. Beta Bionics focuses on innovative insulin delivery solutions, including the FDA-cleared iLet…
electroCore, Inc. announces the issuance of two new U.S. patents expanding its intellectual property portfolio covering non-invasive vagus nerve stimulation (nVNS) technology. These patents enhance protection of their core platforms and related wellness products, potentially extending patent coverage into the late 2030s and beyond, reinforcing elec…
Arbor Realty Trust, Inc. declared dividends for its Series D, E, and F cumulative redeemable preferred stocks, payable on April 30, 2026. The dividend payments reflect accrued amounts and reaffirm the company's commitment to its preferred shareholders amid its ongoing real estate finance operations.
Terra Innovatum Global N.V., trading as NKLR on NASDAQ, announced the appointment of Kathy Williams, former CEO and CFO of AREVA, as Chief Financial Officer. This leadership enhancement supports the company's transition towards commercial scaling and readiness for its Construction Permit Application with the U.S. Nuclear Regulatory Commission. The …
Toll Brothers, a leading US luxury home builder, announced the last opportunity for buyers to purchase new luxury homes at the nearly completed Weston Reserve community in Apex, North Carolina. The enclave offers a limited number of quick move-in homes ranging from approximately 4,050 to 5,155+ square feet, with prices starting at $1.68 million. Th…
AXIL Brands, Inc. announced the nationwide rollout of its flagship electronic hearing protection products, GSX 3.0 and XCOR Pro, in Sportsman’s Warehouse stores and online. This strategic partnership enhances accessibility for hunting, shooting, and outdoor customers seeking advanced tactical earbuds with superior noise reduction and hearing enhanc…
Prairie Operating Co. announced transformational 2025 results with a 3000% revenue increase to $241.6 million (approx. $315 million including Bayswater), record Adjusted EBITDA of $155.5 million (approx. $220 million including Bayswater), and a nearly 3900% rise in production. The company successfully integrated the Bayswater asset acquisition, exp…
UroGen Pharma announced the publication of pivotal Phase 3 ENVISION trial results for ZUSDURI, their mitomycin-based treatment for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC). The trial showed a 72.2% probability of remaining event-free at 24 months after complete response, marking the first FDA-approved n…
VisionWave Holdings provided a corporate update detailing its strategic advancement towards developing an integrated multi-domain intelligence platform encompassing RF sensing, AI infrastructure, autonomous systems, computational acceleration, and subsurface intelligence. The company highlighted recent milestones including completion of the first s…
Xos, Inc. will exhibit its mobile, turnkey energy solutions at the 39th Annual Southern California Facilities Expo, targeting facilities engineering and energy management professionals. The company offers rapidly deployable, grid-independent charging infrastructure that bypasses costly and slow utility upgrades, protecting energy budgets and facili…
SeaStar Medical showcased new clinical data from its QUELIMMUNE SAVE Registry demonstrating no device-related adverse events and improved survival rates in pediatric patients with life-threatening Acute Kidney Injury (AKI). Additionally, mechanistic research highlighted how the Selective Cytopheretic Device (SCD) therapy modulates immune cells towa…
Teladoc Health has appointed Susan Salka, former President and CEO of AMN Healthcare Services, to its board of directors. Salka brings extensive experience in healthcare leadership and governance, expected to support Teladoc's growth and transformation in virtual care. She will join audit and compensation committees and succeeds retiring board memb…
Shoals Technologies Group, a leader in electrical infrastructure for energy markets, will participate in a Barclays-hosted virtual webinar to discuss their BESS products, market strategies, and competitive advantages. The session is open to the public and aims to increase investor awareness about Shoals' role in battery energy storage systems and r…
Jasper Therapeutics announced its Q4 and full-year 2025 financial results alongside significant clinical updates. The company reported positive data from its briquilimab studies targeting chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and asthma, highlighting rapid and durable disease control. They are finalizing dose sel…
Saia, Inc. will release its first quarter 2026 financial results on April 30, 2026, before the market opens. The company's management will host a conference call the same day at 10:00 a.m. Eastern Time to discuss the results, accessible via phone and webcast. A replay will be available for a month after the call.
